Nuwellis, Inc. To Report First Quarter 2025 Financial Results on May 13, 2025

Company Overview - Nuwellis, Inc. is a commercial-stage medical technology company focused on transforming the lives of patients suffering from fluid overload through science, collaboration, and innovation [3] - The company is headquartered in Minneapolis and has a wholly owned subsidiary in Ireland [3] Product Information - Nuwellis is focused on commercializing the Aquadex SmartFlow® system, which is designed for ultrafiltration therapy to remove excess fluid from patients suffering from hypervolemia [3][4] - The Aquadex SmartFlow system is indicated for temporary use (up to 8 hours) or extended use (longer than 8 hours) in adult and pediatric patients weighing 20 kg or more, whose fluid overload is unresponsive to medical management, including diuretics [4] Financial Results Announcement - Nuwellis will release its financial results for the first quarter of 2025 on May 13, 2025 [1] - A conference call and webcast will be hosted at 9:00 AM ET to discuss the financial results and provide a general business update [1]